Morgan Stanley (NYSE:MS – Get Free Report) issued its quarterly earnings results on Wednesday. The financial services provider reported $3.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.89 by $0.57, FiscalAI reports. Morgan Stanley had a net margin of 14.65% and a return on equity of 17.70%. The company had revenue of $21.35 billion for the quarter, compared to the consensus estimate of $19.67 billion.
Morgan Stanley Price Performance
Shares of NYSE MS opened at $228.17 on Wednesday. The firm has a market cap of $359.89 billion, a PE ratio of 20.67, a PEG ratio of 1.67 and a beta of 1.23. Morgan Stanley has a 1-year low of $135.26 and a 1-year high of $232.11. The company has a fifty day moving average price of $209.98 and a 200 day moving average price of $187.94. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 3.52.
Insider Buying and Selling at Morgan Stanley
In other Morgan Stanley news, insider Daniel A. Simkowitz sold 14,690 shares of Morgan Stanley stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $189.24, for a total transaction of $2,779,935.60. Following the completion of the transaction, the insider owned 365,802 shares of the company’s stock, valued at $69,224,370.48. The trade was a 3.86% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Andrew M. Saperstein sold 51,668 shares of the company’s stock in a transaction on Thursday, April 16th. The stock was sold at an average price of $188.59, for a total value of $9,744,068.12. Following the completion of the sale, the insider owned 282,142 shares of the company’s stock, valued at $53,209,159.78. This trade represents a 15.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 77,476 shares of company stock worth $14,644,762 over the last three months. Corporate insiders own 0.17% of the company’s stock.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several research analysts have recently weighed in on the stock. Citigroup lifted their price target on shares of Morgan Stanley from $194.00 to $220.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. Citizens Jmp restated a “market perform” rating on shares of Morgan Stanley in a research report on Thursday, April 16th. BMO Capital Markets lifted their target price on shares of Morgan Stanley from $220.00 to $240.00 and gave the company an “outperform” rating in a report on Monday, June 29th. Wolfe Research cut their price target on Morgan Stanley from $221.00 to $197.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 1st. Finally, Rothschild & Co Redburn raised their price objective on shares of Morgan Stanley from $183.00 to $195.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Morgan Stanley presently has a consensus rating of “Moderate Buy” and a consensus price target of $215.20.
Check Out Our Latest Research Report on MS
More Morgan Stanley News
Here are the key news stories impacting Morgan Stanley this week:
- Positive Sentiment: Expectations are rising that Morgan Stanley will post strong Q2 results, with analysts pointing to better trading activity, firmer investment-banking fees, and improved net interest income as potential upside drivers. Article Title
- Positive Sentiment: Broader bank earnings optimism is also supporting MS, after major lenders delivered strong Q2 updates and analysts said the sector could surprise to the upside across the board. Article Title
- Positive Sentiment: Cooling inflation has reduced pressure on interest rates, improving the backdrop for equities and financials ahead of the earnings release. Article Title
- Neutral Sentiment: Several articles are simply previews of Morgan Stanley’s upcoming earnings and dividend setup, reinforcing that the stock is in a wait-and-see phase until the report is out. Article Title
- Neutral Sentiment: Market commentary also noted Morgan Stanley’s own valuation looks stretched after a strong run, which could limit upside if earnings merely meet expectations rather than exceed them. Article Title
Morgan Stanley announced that its Board of Directors has authorized a share repurchase plan on Wednesday, June 24th that permits the company to repurchase $20.00 billion in outstanding shares. This repurchase authorization permits the financial services provider to purchase up to 5.6% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s board of directors believes its stock is undervalued.
About Morgan Stanley
Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.
The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.
Read More
- Five stocks we like better than Morgan Stanley
- Tower Semiconductor’s AI Rally Is Built on a Light-Speed Bet
- Marriott vs. Viking: Why the Better Quarter Doesn’t Mean the Better Decade
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.
